ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anthony P. C. Yim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yim, A. P. C.
Right arrow Articles by Ho, J. K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yim, A. P. C.
Right arrow Articles by Ho, J. K. S.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:1655-1658
© 1996 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion

Anthony P. C. Yim, MD, Anthony T. C. Chan, MB, BS, Tak Wai Lee, FRCS(E), Innes Y. P. Wan, MB, ChB, Jonathan K. S. Ho, MD

Division of Cardiothoracic Surgery, Department of Surgery, and Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

Accepted for publication July 22, 1996.

Background. Talc has been generally accepted to be the most effective sclerosant for chemical pleurodesis, although the optimal route of administration remains unclear.

Methods. We designed a prospective, randomized study to compare video-assisted thoracoscopic talc insufflation with bedside talc slurry in the treatment of malignant pleural effusion. From September 1993 to November 1995, 57 patients were recruited and randomized to either video-assisted thoracoscopic talc insufflation under general anesthesia (n = 28) or talc slurry by the bedside (n = 29). Patients with poor general condition (Karnofsky score less than 30%), poor pulmonary function (forced expiratory volume in 1 second less than 0.5 L), or trapped lungs were excluded from this study. Five grams of purified talc was used for either video-assisted thoracoscopic talc insufflation or talc slurry.

Results. There was no statistically significant difference between the two groups of patients with respect to age, sex ratio, chest drainage duration, postprocedural hospital stay, parenteral narcotics requirement, complications, or procedure failure (ie, recurrence).

Conclusions. Video-assisted thoracoscopic talc insufflation has not been shown to be a superior approach compared with talc slurry in our study. Because the former demands more resources, we advocate that talc slurry should be considered as the procedure of choice in the treatment of symptomatic malignant pleural effusion in patients who do not have trapped lungs.


Related Article

Invited Commentary
Watts R. Webb
Ann. Thorac. Surg. 1996 62: 1658. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 ChestHome page
R. M. Terra, J. J. M. Junqueira, L. R. Teixeira, F. S. Vargas, P. M. Pego-Fernandes, and F. B. Jatene
Is Full Postpleurodesis Lung Expansion a Determinant of a Successful Outcome After Talc Pleurodesis?
Chest, August 1, 2009; 136(2): 361 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. C. G. Lee and S. Wilkosz
Malignant Pleural Effusions: Fixing the Leaky Faucet
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 3 - 5.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Tremblay, C. Mason, and G. Michaud
Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis
Eur. Respir. J., October 1, 2007; 30(4): 759 - 762.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. R. Haas, D. H. Sterman, and A. I. Musani
Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach
Chest, September 1, 2007; 132(3): 1036 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Stefani, P. Natali, C. Casali, and U. Morandi
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion.: A prospective comparative study
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 827 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Marchi, F. S. Vargas, M. M. Acencio, L. Antonangelo, E. H. Genofre, and L. R. Teixeira
Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis
Eur. Respir. J., November 1, 2006; 28(5): 929 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Rodriguez-Panadero, J. P. Janssen, and P. Astoul
Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion.
Eur. Respir. J., August 1, 2006; 28(2): 409 - 422.
[Full Text] [PDF]

Home page
 ICVTSHome page
T. Laisaar, V. Palmiste, T. Vooder, and T. Umbleja
Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis
Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 307 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure
The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al.
Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion
Chest, March 1, 2005; 127(3): 909 - 915.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Pistolesi and J. Rusthoven
Malignant Pleural Mesothelioma: Update, Current Management, and Newer Therapeutic Strategies
Chest, October 1, 2004; 126(4): 1318 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
Y. C. G. Lee, M. H. Baumann, N. A. Maskell, G. W. Waterer, T. E. Eaton, R. J. O. Davies, J. E. Heffner, and R. W. Light
Pleurodesis Practice for Malignant Pleural Effusions in Five English-Speaking Countries: Survey of Pulmonologists
Chest, December 1, 2003; 124(6): 2229 - 2238.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax, May 1, 2003; 58(90002): ii29 - 38.
[Full Text]

Home page
 ChestHome page
P. A. Kvale, M. Simoff, and U. B. S. Prakash
Palliative Care
Chest, January 1, 2003; 123 (2009): 284S - 311S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn
Management of malignant pleural effusions
Eur. Respir. J., August 1, 2001; 18(2): 402 - 419.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. Sahn
Talc Should Be Used for Pleurodesis
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2023 - 2024.
[Full Text]

Home page
 ThoraxHome page
G ANTUNES and E NEVILLE
Management of malignant pleural effusions
Thorax, December 1, 2000; 55(12): 981 - 983.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Management of Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. H. DIACON, C. WYSER, C. T. BOLLIGER, M. TAMM, M. PLESS, A. P. PERRUCHOUD, and M. SOLER
Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1445 - 1449.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. M. de Campos, L. O. A. Filho, E. d. C. Werebe, H. Sette Jr., A. Fernandez, L. T. B. Filomeno, and F. B. Jatene
Thoracoscopy and Talc Poudrage in the Management of Hepatic Hydrothorax
Chest, July 1, 2000; 118(1): 13 - 17.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer
Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion
Chest, May 1, 2000; 117(5): 1404 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. E. Mitchem, B. L. Herndon, R. M. Fiorella, A. Molteni, C. N. Battie, and G. R. Reisz
Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model
Ann. Thorac. Surg., April 1, 1999; 67(4): 917 - 921.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon
Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis
Radiology, January 1, 1999; 210(1): 277 - 281.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. S. Chambers and A. P. C. Yim
Talc Insufflation Versus Slurry
Ann. Thorac. Surg., August 1, 1997; 64(2): 592 - 593.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. P. C. Yim and M. B. Izzat
Talc Slurry Versus Talc Insufflation Revisited
Ann. Thorac. Surg., July 1, 1997; 64 (1): 285 - 285.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.